Clinical Trial Update: A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial comparing YM150 with enoxaparin for prevention of venous thromboembolism in patients undergoing hip replacement, spanning Phase 2 and Phase 3 a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Thromboembolism

Drugs mentioned

• Enoxaparin (enoxaparin sodium)
• YM150

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Venous Thromboembolism, Arthroplasty, Replacement, Hip | Phase 2, Phase 3 | Status: COMPLETED